Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
BACKGROUND In the U.S. Food and Drug Administration (FDA) clinical trials of left atrial appendage (LAA) closure, a postimplantation peridevice leak (PDL) of ≤5 mm (PDL≤5) was accepted as sufficient LAA "closure." However, the clinical consequences of ...
S. Dukkipati +12 more
semanticscholar +1 more source
Thrombus aspiration in the left atrial appendage: an option or a walk on the tightrope?
To the Editor, The presence of a thrombus in the left atrial appendage is a formal contraindication for its percutaneous closure and poses a serious dilemma during the therapeutic management of the patient.
Rafael J. Ruiz-Salmerón +5 more
doaj +1 more source
Percutaneous interventions in elderly patients with atrial fibrillation: Left atrial ablation and left atrial appendage occlusion [PDF]
Percutaneous MitraClip placement for treatment of severe mitral regurgitation in high surgical risk patients is a commonly performed procedure and requires a transseptal puncture to reach the left atrium.
Lebedev, D. (Dmitry) +2 more
core +12 more sources
Randomized Trial of Surgical Left Atrial Appendage Closure:Protection Against Cerebrovascular Events [PDF]
Following open-heart surgery, atrial fibrillation and stroke occur frequently. Left atrial appendage closure added to elective open-heart surgery could reduce the risk of ischemic stroke.
Al-Farra, Gina +13 more
core +1 more source
BackgroundTranscatheter left atrial appendage closure is an alternative therapy for stroke prevention in atrial fibrillation patients. These procedures are currently guided with transesophageal echocardiography and fluoroscopy in most centers.
Yae Matsuo +9 more
doaj +1 more source
Endovascular retrieval of left atrial appendage closure device embolized to the aorta
Patients with atrial fibrillation with contraindications to anticoagulation can undergo left atrial appendage closure with a device. Hours after a 73-year-old man had undergone left atrial appendage closure, he lost perfusion to his lower extremities ...
Crista E. Horton, MD +3 more
doaj +1 more source
Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation [PDF]
Background Transcatheter left atrial appendage occlusion (LAAO) is a promising therapy for stroke prophylaxis in non-valvular atrial fibrillation (NVAF) but its cost-effectiveness remains understudied. This study evaluated the cost- effectiveness of LAAO
Chow, Ines Hang-Iao +6 more
core +3 more sources
Minimally Invasive Mitral Valve Surgery II: Surgical Technique and Postoperative Management. [PDF]
Techniques for minimally invasive mitral valve repair and replacement continue to evolve. This expert opinion, the second of a 3-part series, outlines current best practices for nonrobotic, minimally invasive mitral valve procedures, and for ...
Agnihotri, Arvind K +25 more
core +1 more source
Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set. [PDF]
BACKGROUND: Studies on stroke risk following cardiac procedures addressed only perioperative and long-term risk following limited higher-risk procedures, were poorly generalizable, and often failed to stratify by stroke type. We calculated stroke risk in
Dhamoon, Amit S. +5 more
core +2 more sources
5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
BACKGROUND The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that left atrial appendage closure (LAAC) with the Watchman device (Boston Scientific, St.
V. Reddy +10 more
semanticscholar +1 more source

